Detalhe da pesquisa
1.
Current Systemic Therapy in Men with Metastatic Castration-Sensitive Prostate Cancer.
Curr Oncol Rep
; 26(5): 488-495, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38592590
2.
Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma.
Eur Radiol
; 30(9): 5021-5028, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32323012
3.
Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations.
Breast J
; 25(1): 16-19, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30414230
4.
Atezolizumab in urothelial bladder carcinoma.
Future Oncol
; 14(4): 331-341, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29135284
5.
Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials.
BMC Med
; 12: 132, 2014 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25285786
6.
Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.
Ther Adv Urol
; 16: 17562872241229876, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425504
7.
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.
Cancers (Basel)
; 16(8)2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672547
8.
Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma.
Eur J Cancer
; 204: 114048, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653033
9.
Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.
Eur J Cancer
; 182: 107-114, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758475
10.
Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer.
Clin Transl Radiat Oncol
; 41: 100637, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37206411
11.
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.
Cancers (Basel)
; 15(4)2023 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831409
12.
Immune-related generalised oedema - A new category of adverse events with immune checkpoint inhibitors.
Eur J Cancer
; 179: 28-47, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473326
13.
Very Long-Term Complete Remission Can Be Achieved in Men With High-Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial.
Clin Genitourin Cancer
; 21(5): 615.e1-615.e8, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37263910
14.
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.
Clin Cancer Res
; 29(21): 4504-4517, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37364000
15.
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer.
Eur Urol Oncol
; 2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433714
16.
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.
Drugs
; 82(7): 719-733, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511402
17.
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 23(6): e377-e383, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660356
18.
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.
Cancer Discov
; 12(4): 958-983, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179201
19.
[Impact of the use of systemic corticosteroid therapy on the effectiveness of immune checkpoint inhibitors]. / Impact de l'utilisation de la corticothérapie systémique sur l'efficacité des inhibiteurs de points de contrôle immunitaire.
Bull Cancer
; 108(6): 635-642, 2021 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-33888298
20.
Meningeal "Lazarus Response" to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib.
Cancer Manag Res
; 13: 2805-2810, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33814929